These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Repeat hepatectomy for colorectal liver metastases. Adam R; Bismuth H; Castaing D; Waechter F; Navarro F; Abascal A; Majno P; Engerran L Ann Surg; 1997 Jan; 225(1):51-60; discussion 60-2. PubMed ID: 8998120 [TBL] [Abstract][Full Text] [Related]
27. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Petrowsky H; Gonen M; Jarnagin W; Lorenz M; DeMatteo R; Heinrich S; Encke A; Blumgart L; Fong Y Ann Surg; 2002 Jun; 235(6):863-71. PubMed ID: 12035044 [TBL] [Abstract][Full Text] [Related]
28. The predictors and oncological outcomes of repeat surgery for recurrence after hepatectomy for colorectal liver metastases. Imai K; Yamashita YI; Miyamoto Y; Nakagawa S; Okabe H; Hashimoto D; Chikamoto A; Baba H Int J Clin Oncol; 2018 Oct; 23(5):908-916. PubMed ID: 29619592 [TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases. Takahashi S; Inoue K; Konishi M; Nakagouri T; Kinoshita T Surgery; 2003 Jun; 133(6):627-34. PubMed ID: 12796730 [TBL] [Abstract][Full Text] [Related]
30. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study. John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407 [TBL] [Abstract][Full Text] [Related]
31. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection. Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267 [TBL] [Abstract][Full Text] [Related]
32. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy. Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901 [TBL] [Abstract][Full Text] [Related]
33. Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis. Sutton TL; Wong LH; Walker BS; Dewey EN; Eil R; Lopez CD; Kardosh A; Chen EY; Rocha FG; Billingsley KG; Mayo SC Surgery; 2023 Jun; 173(6):1314-1321. PubMed ID: 36435651 [TBL] [Abstract][Full Text] [Related]